In contrast, the ablation of TP53 on both oncogenic backgrounds leads to tumor progression and PDAC, confirming that TP53 is a major tumor-suppressive checkpoint specifically to overcome OIS in the pancreas [59]. The gene discussed is TP53; the disease is neoplasm.